Pcp receptor ligands and the use thereof

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 471/08 (2006.01) A61K 31/55 (2006.01) A61K 31/695 (2006.01) C07F 7/10 (2006.01)

Patent

CA 2050284

The invention relates to methods for the treatment or prevention of neuronal loss in ischemia, hypoxia, hypoglycemia, brain and spinal cord trauma as well as for treatment of Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease, and Down's Syndrome by administering a pharmaceutical composition comprising an effective amount of 10,5-(iminomethano)-10,11-dihydro-5H-dibenzo[a,d]cycloheptene (IDDC) or derivatives thereof to an animal.

L'invention concerne des procédés pour le traitement ou la prévention de la perte ou dégradation de neurones dans l'ischémie, l'hypoxie, l'hypoglycémie, les traumatismes du cerveau et du cordon médullaire ainsi que pour le traitement de la maladie d'Alzheimer, la schlérose latérale amiotrophique, la maladie de Huntington et le syndrome de Down par administration à un animal d'une composition pharmaceutique comprenant une quantité efficace de 10,5-(iminométhano)-10,11-dihydro-5H-dibenzo[a,d]cycloheptène (IDDC) ou des dérivés de ce composé.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pcp receptor ligands and the use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pcp receptor ligands and the use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pcp receptor ligands and the use thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1598026

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.